{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T23:40:28Z","timestamp":1728258028828},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1038\/s41440-024-01813-5","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T07:02:35Z","timestamp":1723100555000},"page":"2939-2941","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is it effective to initiate cilostazol-based dual antiplatelet therapy before achieving blood pressure control? Lessons from the CSPS study"],"prefix":"10.1038","volume":"47","author":[{"given":"Koichi","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"1813_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"Collaborators GBDS.","year":"2021","unstructured":"Collaborators GBDS. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol."},{"key":"1813_CR2","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1161\/01.STR.32.6.1349","volume":"32","author":"CS Kidwell","year":"2001","unstructured":"Kidwell CS, Liebeskind DS, Starkman S, Saver JL. Trends in acute ischemic stroke trials through the 20th century. Stroke. 2001;32:1349\u201359.","journal-title":"Stroke."},{"key":"1813_CR3","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1161\/HYPERTENSIONAHA.120.14653","volume":"76","author":"PB Gorelick","year":"2020","unstructured":"Gorelick PB, Whelton PK, Sorond F, Carey RM. Blood pressure management in stroke. Hypertension. 2020;76:1688\u201395.","journal-title":"Hypertension."},{"key":"1813_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","volume":"358","author":"PC Group","year":"2001","unstructured":"Group PC. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033\u201341.","journal-title":"Lancet."},{"key":"1813_CR5","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:2199\u2013269.","journal-title":"J Am Coll Cardiol"},{"key":"1813_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/17474930221090347","volume":"17","author":"S Miyamoto","year":"2022","unstructured":"Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, et al. Japan Stroke Society Guideline 2021 for the treatment of stroke. Int J Stroke. 2022;17:1039\u201349.","journal-title":"Int J Stroke"},{"key":"1813_CR7","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"1813_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","volume":"382","author":"SPSS Group","year":"2013","unstructured":"Group SPSS, Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507\u201315.","journal-title":"Lancet."},{"key":"1813_CR9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","volume":"76","author":"K Kitagawa","year":"2019","unstructured":"Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, et al. Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 2019;76:1309\u201318.","journal-title":"JAMA Neurol"},{"key":"1813_CR10","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2314741","volume":"390","author":"G Li","year":"2024","unstructured":"Li G, Lin Y, Yang J, Anderson CS, Chen C, Liu F, et al. Intensive ambulance-delivered blood-pressure reduction in hyperacute stroke. N Engl J Med. 2024;390:1862\u201372.","journal-title":"N Engl J Med"},{"key":"1813_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(19)30148-6","volume":"18","author":"K Toyoda","year":"2019","unstructured":"Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2019;18:539\u201348.","journal-title":"Lancet Neurol"},{"key":"1813_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/STROKEAHA.122.039900","volume":"54","author":"Y Nishiyama","year":"2023","unstructured":"Nishiyama Y, Kimura K, Otsuka T, Toyoda K, Uchiyama S, Hoshino H, et al. Dual antiplatelet therapy with cilostazol for secondary prevention in lacunar stroke: subanalysis of the CSPS.com trial. Stroke. 2023;54:697\u2013705.","journal-title":"Stroke."},{"key":"1813_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/17474930221112343","volume":"18","author":"S Uchiyama","year":"2023","unstructured":"Uchiyama S, Toyoda K, Okamura S, Omae K, Hoshino H, Kimura K, et al. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: a subgroup analysis of the CSPS.com trial. Int J Stroke. 2023;18:426\u201332.","journal-title":"Int J Stroke"},{"key":"1813_CR14","doi-asserted-by":"publisher","first-page":"e983","DOI":"10.1212\/WNL.0000000000200064","volume":"98","author":"K Toyoda","year":"2022","unstructured":"Toyoda K, Omae K, Hoshino H, Uchiyama S, Kimura K, Miwa K, et al. Association of timing for starting dual antiplatelet treatment with cilostazol and recurrent stroke: a CSPS.com trial post hoc analysis. Neurology. 2022;98:e983\u2013e992.","journal-title":"Neurology."},{"key":"1813_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.5551\/jat.63660","volume":"30","author":"H Hoshino","year":"2023","unstructured":"Hoshino H, Toyoda K, Omae K, Takahashi K, Uchiyama S, Kimura K, et al. Sex difference in the impact of dual antiplatelet therapy using cilostazol for secondary stroke prevention: a sub-analysis of CSPS.com. J Atheroscler Thromb. 2023;30:675\u201383.","journal-title":"J Atheroscler Thromb"},{"key":"1813_CR16","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1161\/STROKEAHA.121.034378","volume":"52","author":"H Hoshino","year":"2021","unstructured":"Hoshino H, Toyoda K, Omae K, Ishida N, Uchiyama S, Kimura K, et al. Dual antiplatelet therapy using cilostazol with aspirin or clopidogrel: subanalysis of the CSPS.com trial. Stroke. 2021;52:3430\u20139.","journal-title":"Stroke."},{"key":"1813_CR17","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1161\/STROKEAHA.120.029454","volume":"51","author":"C McHutchison","year":"2020","unstructured":"McHutchison C, Blair GW, Appleton JP, Chappell FM, Doubal F, Bath PM, et al. Cilostazol for secondary prevention of stroke and cognitive decline: systematic review and meta-analysis. Stroke. 2020;51:2374\u201385.","journal-title":"Stroke."},{"key":"1813_CR18","doi-asserted-by":"publisher","unstructured":"Toyoda K Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: A post hoc analysis of the CSPS.com trial. Hypertens Res. 2024; https:\/\/doi.org\/10.1038\/s41440-024-01742-3.","DOI":"10.1038\/s41440-024-01742-3"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01813-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01813-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01813-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T23:04:49Z","timestamp":1728255889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01813-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1813"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01813-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}